Amendis vs Genomenon
Amendis vs Genomenon, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amendis is on 36/100 and Genomenon on 2/100.
Where each one leads
Amendis
- our overall score: 36/100 against 2/100
Genomenon
- agent readiness: 34/100 against 21/100
- domain rating: 46/100 against 2/100
- headcount: 137 against 55
- LinkedIn following: 10,643 against 2,037
At a glance
| Measure | Amendis | Genomenon |
|---|---|---|
| What it is | Amendis develops an AI-powered test to assess the risk of tumor spread in the neck, aiming to prevent unnecessary surgeries. | Helps clinicians and researchers interpret millions of genetic variants. |
| Category | Genomics, Healthcare, Diagnostics, Cancer | Genomics, Biotech, HealthTech, MedTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2008 | 2017 |
| Headquarters | Tel Aviv, Israel | Ann Arbor, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Amendis | Genomenon |
|---|---|---|
| Employees | 55 | 137 |
| Headcount growthLast 12 months | +4.6% | Not published |
| Latest round | Bootstrapped | Not published |
| LinkedIn followers | 2,037 | 10,643 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Amendis | Genomenon |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 36/100 | 2/100 |
| Traction | 17/100 | Not published |
| Team | 60/100 | Not published |
| Community | 8/100 | Not published |
| Search visibility | 32/100 | 2/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (34/100) |
| Domain ratingLink authority, 0-100 | 2/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Amendis | Genomenon |
|---|---|---|
| Hosting | Vultr | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Webflow |
| Frameworks | Jquery | Not detected |
| Analytics | Not detected | Google Tag Manager |
What users say
| Measure | Amendis | Genomenon |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 1 thread |
“We are Genomenon! We assist Clinicians and Pathologists in identifying and treating genetic diseases for patients seeking personalized medical care based on their genomic data. Mastermind, by Genomenon, is the first-in-kind genomic search e”r/askscience
Amendis vs Genomenon: common questions
Which is better, Amendis or Genomenon?
On our 0-100 score Amendis rates higher (36/100 against 2/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Amendis and Genomenon compare on the numbers?
Amendis leads on our overall score (36/100 against 2/100). Genomenon leads on agent readiness (34/100 against 21/100), domain rating (46/100 against 2/100), headcount (137 against 55), LinkedIn following (10,643 against 2,037).
What do real users say about Amendis and Genomenon?
Genomenon: 1 positive and 0 negative mentions across 1 Reddit threads we track, mostly in r/askscience.
Read the full Amendis review and pricing or the Genomenon review and pricing. You can also browse other Amendis alternatives we track.